Low Float (Nasdaq: ARTL) Blasts Vertically In Pre-Market, Up Approx. 16%

April 14th

Greetings, Friend!

(Nasdaq: ARTL) has my undivided attention as it sits alone at the top of today's watchlist.

And it’s no surprise why...

ARTL is making waves in pre-market activity, currently showing an approximate 16% climb.

Even more impressive, it briefly pushed past the key $1.00 mark, a potential psychological barrier, ahead of the 9:30AM EST opening bell.

Here’s another important detail: ARTL has a low float, with only about 3.25Mn shares available. This could lead to increased chart volatility potential.

Take a moment to add (Nasdaq: ARTL) to your radar, and stay tuned for more updates this morning.

-----

My complete attention Monday will be on Artelo Biosciences, Inc. (Nasdaq: ARTL).

Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system.

Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy, and inflammation.

Here’s why it’s highly notable right now...

This situation involves a low float. With approximately 3.25Mn shares available and circulating, the possibility of sharp chart shifts may be high.

The small number of available shares in ARTL's float might explain its ability to jump from $1.185 on February 5th, 2025, to $1.5495 the following day.

That’s a surge of over 30% almost instantly!

While outcomes are never certain, having around 3.25Mn shares in its float could increase the likelihood of pronounced chart swings for ARTL.

More details on (Nasdaq: ARTL) will follow. Think about it for your watchlist!

All the best,

Dane James

Editor Market Pulse Today

(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)